Molecular tools that target RNA at specific sites allow recoding of RNA information and processing. SNAP-tagged deaminases guided by a chemically stabilized guide RNA can edit targeted adenosine to inosine in several endogenous transcripts simultaneously, with high efficiency (up to 90%), high potency, sufficient editing duration, and high precision. We used adenosine deaminases acting on RNA (ADARs) fused to SNAP-tag for the efficient and concurrent editing of two disease-relevant signaling transcripts, KRAS and STAT1. We also demonstrate improved performance compared with that of the recently described Cas13b-ADAR.
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NATuRe MeThoDS Fig. 2b ), were caused by the free-floating enzyme, and comprised mainly novel sites (74-85%). Only a small number of sites were edited in a gRNA-dependent manner (∼ 30 sites for each editase; Fig. 2c ). A vast amount of sites were located in the ORF (347-496 sites) and gave rise to nonsynonymous editing (230-347 sites). However, none of the nonsynonymous editing exceeded that at the target site, and the majority of these edits occurred at a low level. This was particularly true for SA1Q, where only 4 of 227 sites were edited more than 50%, and 167 of 227 sites were edited less than 25% (Fig. 2d ). For SA2Q, however, the average editing level was higher, with 20/344 sites above 50% and 240/344 below 25% editing yield. We found SA1Q and SA2Q to share only 414 of their off-target sites. SA1Q and SA2Q differ in their off-target codon preferences, with SA2Q accepting 5′ -CAN triplets better ( Supplementary Fig. 5b ). All SNAP-ADAR cell lines behaved indistinguishably from normal 293 cells with respect to doubling times and morphology, and analysis of the number of fragments per kilobase of transcript per million mapped reads (FPKM) revealed no difference in gene expression due to the presence of (off-target) editing activity ( Supplementary  Fig. 6 ). Because SA1(Q) showed the best balance of efficiency and specificity, we continued with that editase.
RNA editing would be particularly attractive for the manipulation of signaling networks. Also, the editable codons (5′ -UAG, 5′ -UAC, 5′ -UAU, 5′ -UAA, and 5′ -AAG) indicate amino acid substitutions (Thr-to-Ala, Tyr-to-Cys, Ser-to-Gly, and Lys-to-Arg; Supplementary Fig. 5c ) suitable for the manipulation of signaling proteins. For illustration, we edited two 5′ -UAG sites in KRAS mRNA (sites 1 and 2) and the Tyr701 site (5′ -UAU) in STAT1 mRNA, its most relevant phosphorylation site 17 for signaling. With SA1Q, we achieved editing levels of 55% ± 8% (KRAS site 1), 46% ± 2% (KRAS site 2), and 76% ± 6% (STAT1) ( Fig. 2e ). We found no detectable offtarget editing in the gRNA-mRNA duplex ( Supplementary Fig. 7) . gRNA per well (pmol) 
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Again, concurrent editing of either two sites on the KRAS transcript or sites on two transcripts (KRAS and STAT1) was possible without a loss of editing efficiency ( Fig. 2e) . The highly precise editase SA1 was less active, but was still able to obtain yields of 18% ± 3% (KRAS site 1) and 31% ± 2% (STAT1). The chemical modification of our gRNA restricted off-target editing in the mRNA-gRNA duplex. This is in contrast to two competing approaches (one based on Cas13b) 9, 12, 13 that were shown to induce massive global off-target editing caused by the overexpressed editases 9, 15 (Supplementary Tables 2 and 3 ). For SNAP-ADARs, global off-target editing was restricted by genomic integration. It was almost eliminated with the precise editases SA1 and SA2, and editing of endogenous targets was still sufficient for some codons (UAG and UAU). The performance of SA1 was also better than that of the 'high-specificity variant' of Cas13b-ADAR 9 (Supplementary Note 1). Notably, our integrated hyperactive SA1Q and SA2Q showed off-target editing that was orders of magnitude less than that observed with overexpressed Cas13b-ADAR version 1 9 or λ N-deaminases 15 (Supplementary Fig. 8 ). We found that further reduction of SA1Q/SA2Q expression (up to 25-fold) is possible to further reduce off-target editing ( Supplementary Fig. 9 ). One could further improve on the gRNA chemistry 18 or the editase used in our approach 9, 10 . Notably, we tested the reported high-specificity variant of Cas13b-ADAR (T375G), but in the context of SNAP-ADAR ( Supplementary Fig. 10 ). In contrast to previous claims 9 , we found this mutant to be much less efficient than SA1Q/SA2Q, and even inferior to SA1/2. Compared with those used in other approaches, our gRNAs are extremely short (22 nt). Thus editing clearly depends on the targeting mechanism and will not interfere with endogenous ADARs 8 . However, we found that the long Cas13b gRNAs (85 nt) recruited overexpressed human ADAR2, as well as SA2Q, to elicit editing of a cotransfected reporter at levels similar to those observed with Cas13b-ADAR ( Supplementary Fig. 11 ). This observation raises the question of the extent to which previously reported edits 9 were affected by overexpression artifacts (Methods, Supplementary Note 2). Finally, the small size (20 kDa) and human origin of the SNAP-tag provide further advantages over Cas13-ADAR. Together, our results set a new benchmark for site-directed RNA editing and provide a tool ready for use in concurrent editing of endogenous transcripts. The target site (ACTB) is indicated by an arrow in each plot. Significantly differently edited sites (P < 0.01) are indicated by red dots. In b, editing is compared with that in a control cell line that did not express any SA protein. c, Editing in the presence versus in the absence of gRNA. d, Nonsynonymous off-target sites ranked by editing yield. Experiments were carried out in duplicate. e, Editing of signaling transcripts. Two 5′ -UAG sites in the ORF of the KRAS transcript (sites 1 and 2) and a 5′ -UAU site in the STAT1 transcript (Tyr701) were targeted. For concurrent editing, two respective gRNAs were cotransfected into SA1Q + cells. Data in a,e are shown as the mean ± s.d.; n = 3 independent experiments; black dots represent individual data points. Significance in b,c was tested by Fisher's exact test (two-sided); n = 2 independent experiments. Numbers represent the number of sites that were significantly differently edited compared with sites in a related control cell line that did not express the respective SA editase. Syn., synonymous; nonsyn., nonsynonymous. a Editing was carried out in cells expressing the given SNAP-ADAR in the presence of a BG-gRNA targeting the ACTB transcript. b "Others" refers to editing in introns, intergenic regions, and noncoding RNA.
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Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41592-018-0017-z.
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Methods BG-gRNA synthesis. Synthesis of chemically modified BG-gRNAs does not require any chemistry equipment. All chemical modifications used in this study are commercially available. The benzylguanine (BG) modification can be achieved by application of a commercial amino or thiol reactive BG derivative such as BGmaleiimide (New England Biolabs). The sequences and chemical modifications of all gRNAs are presented in Supplementary Table 4 . For this study, all NH 2 -gRNAs were purchased from Biospring (Germany) as HPLC-purified single-stranded RNAs with a 5′ -C6 amino linker. As an alternative to commercial BG derivatives, our protocol can be used to introduce the BG moiety. BG connected to a carboxylic acid linker 2,3 (12 µ l, 60 mM in DMSO) was activated in situ as an OSu-ester by incubation with EDCI·HCl (12 µ l, 17.4 mg/ml in DMSO) and NHS (12 µ l, 17.8 mg/ml in DMSO) for 1 h at 30 °C. Then, the NH 2 -gRNA (25 µ l, 6 µ g/µ l) and DIPEA (12 µ l, 1:20 in DMSO) were added to the preactivation mix and incubated (90 min, 30 °C) 19 . The crude BG-gRNA was purified from unreacted NH 2 -gRNA by 20% urea PAGE and then extracted with H 2 O (700 µ l; overnight at 4 °C). RNA precipitation was done with sodium acetate (0.1 volumes, 3.0 M) and ethanol (3 volumes, 100%, overnight at -80 °C). The BG-gRNA was washed with ethanol (75%) and dissolved in water (60 µ l).
SNAP-ADAR-expressing cell lines.
Each enzyme was integrated as a single copy under control of the doxycycline-inducible CMV promoter at the FRT site into the genome of Flp-In 293 cells (R78007; Thermo Fisher Scientific) as described 8 .
The exact cDNAs are listed in Supplementary Note 4. Enzyme expression of all four enzymes was inducible by doxycycline (10 ng/ml) to roughly similar levels as validated by western blotting and fluorescence microscopy (Supplementary Fig. 12 and Supplementary Note 3). Also at the RNA level, the expression levels of SA1 (wild-type and Q) and SA2 (wild-type and Q) were roughly similar, with average FPKM values of 679 and 814 for SA1(Q) and SA2(Q), respectively. The E> Q mutation did not change the protein localization (Supplementary Note 3). SA1(Q) is localized to cytoplasm and nucleoplasm; SA2(Q) is mainly localized to cytoplasm. To determine the location of the different SNAP-ADAR proteins, we seeded 1 × 10 5 cells in 500 µ l of selection media with or without doxycycline (10 ng/ml) on poly-d-lysine-coated coverslips in a 24-well format. After 1 d, we carried out BG-FITC labeling of the SNAP-tag and nuclear staining. To validate SNAP-ADAR protein amounts, we performed western blotting analysis. For this, 3 × 10 5 cells were seeded in 500 µ l of selection media with or without doxycycline (10 ng/ml) in a 24-well format for 1 d. Then, cells were lysed with urea buffer (8 M urea in 10 mM Tris, 100 mM NaH 2 PO 4 , pH 8.0). Protein lysate (5 µ g) was separated by SDS-PAGE and transferred onto a PVDF membrane (Bio-Rad Laboratories) for immunoblotting with primary antibodies to the SNAP-tag (1:1,000; P9310S; New England Biolabs) and β -actin (1:40,000; A5441; Sigma-Aldrich). Afterwards, the blot was incubated with HRP-conjugated secondary antibodies against rabbit (1:10,000; 111-035-003; Jackson ImmunoResearch Laboratories) and mouse (1:10,000; 115-035-003; Jackson ImmunoResearch Laboratories) and visualized by enhanced chemiluminescence.
RNA-editing experiments.
General. Flp-In T-REx 293 cells stably transfected with the respective SNAP-ADAR-expressing pcDNA5 vector were grown in DMEM with 10% FBS, 100 µ g/ml hygromycin B, and 15 µ g/ml blasticidin S. For experiments, 3 × 10 5 cells per well were seeded in 24-well plates, and gene expression was induced by doxycycline (10 ng/ml) for 1 d. Then, 8 × 10 4 cells per well were resuspended in 100 µ l of DMEM with 10% FBS and 15 ng/ ml doxycycline and reverse-transfected in a 96-well format with the gRNA transfection mixture (39 fmol to 40 pmol of gRNA and 0.75 µ l of Lipofectamine 2000 in 50 µ l of OptiMEM; the exact amounts of gRNA used in this study are given in Supplementary Table 4 ). After 24 h, cells were collected for RNA isolation. When determining editing yields at later time points, we resuspended the cells in DMEM with 10% FBS and 10 ng/ml doxycycline and seeded them into 24-well plates. 48 h later, we added fresh medium containing 10% FBS and 10 ng/ml doxycycline to the cells. RNA was extracted with the RNeasy MinElute kit (Qiagen) and treated with DNase I. After DNA digestion, RNA was converted into cDNA for subsequent amplification by Taq DNA PCR. The DNA was analyzed by Sanger sequencing (Eurofins Genomics, Germany). We quantified A-to-I editing yields by measuring the height of the resulting guanosine peak divided by the sum of the peak heights of the guanosine and adenosine peaks at a respective site. In general, negative controls were run for all experiments and never showed detectable editing.
Potential editing at the DNA versus the RNA level. To check for potential A-to-I editing of the genomic DNA beside the targeted RNA, we used the innuPREP DNA/RNA mini kit (Analytik Jena, Germany) to extract genomic DNA and RNA from cells in parallel. We followed the manufacturer's protocol. Cellular RNA was further reverse-transcribed as described above, and the genomic DNA was immediately amplified by Taq DNA PCR and sequenced without reverse transcription. No A-to-G change in the DNA was detectable ( Supplementary Fig. 13 ).
Potency and time dependency. For the potency and the time-dependence experiments, RNA was isolated with 500 µ l of TRI reagent (Sigma-Aldrich).
Chloroform (100 µ l) was added to extract the RNA for precipitation with isopropanol (350 µ l) in the presence of linear acryl amide (1.5 µ l; 5 mg/ml). The RNA pellet was washed twice (500 µ l of 75% ethanol) and was then dissolved in RNase-free water (30 µ l). Furthermore, we tested whether the editing efficiency and potency were dependent on the formation of the covalent bond between gRNA and SNAP-ADAR. gRNAs that lacked the BG moiety could elicit substantial editing only with the hyperactive enzymes (up to 70% editing yield), and required ∼ 50fold higher amounts of gRNA (ED 50 (effector dose for a half-maximum response) ~ 6-7 pmol per well; Supplementary Fig. 14) . With the wild-type enzymes, no substantial editing was obtained even at the highest gRNA concentration (20 pmol per well). The target site in the potency screen was UAG site 2 in the ORF of endogenous GAPDH mRNA. The target in the time-dependency screen was a 5′ -UAG site in the 3′ -UTR of endogenous GAPDH mRNA.
Triplet scope. When studying the editing scope with all 16 5′ -NAN triplets, we chose targets such that no amino acid change resulted. For four triplets, sites had to be chosen that elicited amino acid changes. Then, sites were selected that were expected not to interfere with GAPDH activity (Supplementary Note 4) .
Applicability. In terms of maximum yield (up to 90%), potency (≥ 1 pmol per well), and duration (several days), site-directed RNA editing behaves similarly to RNA interference with transfected short interfering RNAs 20 in cell culture and may allow numerous applications. However, it is difficult to reliably predict the outcome of an editing reaction from the triplet preference alone (Fig. 1e ). The accessibility of an arbitrary target might be limited by RNA secondary structure, RNA-binding proteins 21 , low mRNA copy numbers, and short half-lives.
Off-target editing. Accurate analyses uncovered an example of off-target editing at the targeted transcript but outside the gRNA-mRNA duplex. This was undetectable for SA1/2, but was found for SA1Q (50% editing of one AAG triplet in GAPDH mRNA) and for SA2Q (70% editing of a CAG site in GAPDH mRNA). These two strongly edited sites in GAPDH mRNA were predicted by mfold to be located in highly double-stranded regions of the transcript ( Supplementary  Fig. 15 ). In accordance, editing yields correlated with the proximity of the gRNA binding site, reminiscent of the recently described TRIBE method to elucidate binding sites of RNA-binding proteins 22 .
Next-generation RNA-sequencing experiments. The RNA editing was done by transfection of 5 pmol of gRNA targeting a 5′ -UAG triplet in the 3′ -UTR of ACTB mRNA into the respective Flp-In cell line as described above. Overall, seven settings were implemented, each with an independent duplicate: (1) empty lipofection into empty (i.e., not expressing SA proteins) Flp-In 293 cells, (2) gRNA lipofection into SA1 + cells, (3) gRNA transfection into SA2 + cells, (4) empty transfection into SA1Q + cells, (5) empty transfection into SA2Q + cells, (6) gRNA transfection into SA1Q + cells, and (7) gRNA transfection into SA2Q + cells. RNA was isolated with the RNeasy MinElute kit, treated with DNase I, and purified again with the RNeasy MinElute kit. Purified RNA (1.2 µ g) was delivered to CeGaT (Germany) for poly(A) + mRNA sequencing. The library was prepared from 100 ng of RNA with the TruSeq stranded mRNA library prep kit (Illumina) and sequenced with a HiSeq 4000 (50 million reads, 2 × 100 bp paired end; Illumina).
Mapping of RNA-seq reads. We adopted a previously published pipeline to accurately align RNA-seq reads onto the genome 23, 24 . We used BWA 25 to align the reads to a combination of the reference genome sequences and exonic sequences surrounding known splicing junctions from known gene models. Each of the paired-end reads was mapped separately using the commands "bwa aln fastqfile" and "bwa samse -n4. " We then chose a length of the splicing junction that was slightly shorter than the RNA-seq reads to prevent redundant alignment (i.e., 95 bp for reads 100 bp in length). The reference genome used was hg19, and the gene models were obtained through the UCSC Genome Browser for Gencode, RefSeq, Ensembl, and UCSC Genes. We considered only uniquely mapped reads with mapping quality q > 10 and used SAMtools rmdup 26 to remove clonal reads (PCR duplicates) mapped to the same location. Of these identical reads, only the read with the highest mapping quality was kept for downstream analysis. Unique and nonduplicate reads were subjected to local realignment and base-score recalibration using the IndelRealigner and TableRecalibration from the Genome Analysis Toolkit (GATK) 27 . The above steps were applied separately to each of the RNA-seq samples.
Identification of editing sites from RNA-seq data. We used the UnifiedGenotyper from GATK 27 to call variants from the mapped RNA-seq reads. In contrast to the usual practice of variant calling, we identified the variants with relatively loose criteria by using the UnifiedGenotyper tool with options stand_call_conf 0, stand_emit_conf 0, and output mode EMIT_VARIANTS_ONLY. Variants from nonrepetitive and repetitive non-Alu regions were required to be supported by at least three reads containing mismatches between the reference genome sequences and RNA-seq data. Supporting of one mismatched read was required for variants in Alu regions. We subjected this set of variant candidates to several filtering steps to increase the accuracy of editing-site calling. We first removed all known
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NATuRe MeThoDS human single-nucleotide polymorphisms (SNPs) present in dbSNP (except SNPs of molecular type 'cDNA'; database version 135; http://www.ncbi.nlm.nih.gov/SNP/), the 1000 Genomes Project, and the University of Washington Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). To remove false positive RNA-seq variant calls due to technical artifacts, we applied further filters as previously described 23, 24 . In brief, we required a variant call quality Q > 20 23, 24 , discarded variants if they occurred in the first six bases of a read 25 , removed variants in simple repeats 26 , removed intronic variants that were within 4 bp of splice junctions, and discarded variants in homopolymers 27 . Moreover, we removed sites in highly similar regions of the genome by BLAT 28 . Finally, variants were annotated with ANNOVAR 29 on the basis of gene models from Gencode, RefSeq, Ensembl, and UCSC. The resulting sets of sites identified from RNA-seq data were compared with all sites available in the RADAR database 16 and were subsequently referred to as 'known' sites if also found in RADAR, or 'novel' sites if not found.
Identification of significantly differently edited sites. We quantified editing levels of edited sites with coverage of ≥ 50 reads (combined coverage of both replicates) and performed Fisher's exact tests (adjusted P < 0.01) to identify significantly differently edited sites across the samples (editing difference > 10%). Additional next-generation sequencing (NGS) quality data are given in Supplementary Note 4.
Benchmarking with Cas13b-ADAR and λN-deaminases. The SNAP-ADAR approach was benchmarked against the recently published Cas13b-ADAR approach (Supplementary Notes 1 and 2, Supplementary Table 2 , and Supplementary Figs. 10 and 11 ). First, we repeated the editing of KRAS mRNA sites 1 and 2 with SA1 and SA1Q. We observed that SA1Q achieved better editing yields than Cas13b-ADAR version 1 (e.g., 50-65% compared with 15-25% for KRAS site 1), SA1 was better than Cas13b-ADAR version 2 (e.g., 18-20% versus ~12%), editing depended strictly on the targeting mechanism, and there was no off-target editing in the mRNA-gRNA duplex (Supplementary Note 1). ADARs are known to edit double-stranded RNA substrates of > 30 bp readily. We wondered whether large Cas13-gRNAs (85 nt, 50-bp duplex) are able to recruit human ADAR or any other ADAR fusion protein independently of a specific targeting mechanism. Indeed, we found that such 50-bp gRNAs recruited overexpressed ADAR2 but also engineered SA2Q to elicit editing of a cotransfected reporter transcript at levels similar to those achieved with Cas13-ADAR (~25-30%; Supplementary  Fig. 11, Supplementary Note 2) . This medium-level editing was apparently due to self-targeting of the deaminase (domain) alone and independent of a specific targeting mechanism. Most of the experiments reported by Cox et al. 9 were done under such co-overexpression conditions, and it remains unclear to what extent their results rely on a true (Cas-dependent) targeting mechanism and which, if any, are overexpression artifacts (self-targeting). The lack of codon preference reported for repairV1 (with 10-35% editing yields) could be impaired by this. Cox et al. 9 argue that Cas-ADAR has a weak codon preference due to tight binding of the Cas protein to the mRNA-gRNA complex, but in our opinion they do not report sufficient data or controls to support this. In the worst case, a very stable long RNA duplex wrapped by Cas-ADAR could inhibit translation, in particular when the start codon is close or even included, as this is given for the KRAS transcript they reported on (Supplementary Note 1). As we have shown here in the context of SNAP-ADARs, translation inhibition with puromycin can indeed increase editing levels in the ORF ( Supplementary Fig. 3 ). In this respect, it is notable that we have tested the mutation from their 'high-specificity' Cas-ADAR repair version 2 (T375G), but in the context of SNAP-ADAR. For this, we genomically integrated SA2QG (E488Q + T375G) and tested it side-by-side with SA1 and SA2 for the editing of five codons in the ORF of the GAPDH transcript (UAG, CAA, CAG, AAG, and GAU). SA2QG elicited only minor editing at the UAG codon (15%) and no significant yield with the other four codons ( Supplementary  Fig. 10 ). It was always less active than the two wild-type SA enzymes, which produced editing at some of the codons (~40% at UAG, 23-66% at CAA, 18% at CAG). In the ORF, SA2QG seemed unable to edit even the preferred UAG codon sufficiently. However, editing was successful when we targeted a UAG triplet in the 3′ -UTR of GAPDH mRNA (80% SA2QG, 85-90% for wild-type SA enzyme). Unfortunately, Cox et al. 9 do not comprehensively characterize repairV2 or show whether and how it promotes the editing reaction. Notably, our data predict that the wild-type deaminase would always be the better choice (compared with repairV2) to achieve decent editing at preferred codons with manageable off-target edits also in the context of Cas-ADAR. The true mechanism of Cas-ADARdirected RNA editing and how it can be best applied remain partly unclear. We also provide a side-by-side comparison with the λ N-deaminase approach ( Supplementary Table 3 ) and reanalyzed the NGS data from Vallecillo-Viejo et al 15 .
with our pipeline ( Supplementary Fig. 8 ). In comparison, our wild-type SA1/SA2 enzymes were highly precise and provoked several-hundred-fold less off-target editing. Our hyperactive enzymes SA1Q and SA2Q were less prone to off-target editing than the wild-type versions of the λ N-deaminases and much less off-target prone than the hyperactive version of the λ N-deaminases.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. 
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Describe the software used to analyze the data in this study.
As outlined in full detail in the online methods all software tools used for NGS are publically available: Mapping of RNA-seq and reads: BWA was used to align the reads to a combination of the reference genome sequences (hg19) and exonic sequences surrounding known splicing junctions from known gene models, obtained through the UCSC Genome Browser for Gencode, RefSeq, Ensembl, and UCSC Genes. Unique and non-duplicate reads were subjected to local realignment and base score recalibration using the IndelRealigner and TableRecalibration from the Genome Analysis Toolkit (GATK For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
The protocol is provided in the manuscript: primary antibodies have been used against the SNAP-tag (1:1000, P9310S, New England Biolabs, USA) and ß-actin (1:40000, A5441, Sigma Aldrich, USA). Both antibodies are well established commercial antibodies. The SNAP-tag antibody was validated by the fact that total protein from parental empty cells (not expressing a SNAP-tagged protein) do not stain in the immunoblot. After integration of the SNAP-tagged protein, the total protein showed a clear doxycycline-inducible protein band of the expected size. The secondary antibodies were HRP-conjugated anti-rabbit (1:10000, 111-035-003, Jackson Immuno Research Laboratories, USA) and anti-mouse (1:10000, 115-035-003, Jackson Immuno Research Laboratories, USA). Both are well-known and validated commercial secondary antibodies. the study did not involve human research participants
